Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies-Reference-Cited by-同舟云学术

Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies

Published:2021-07-19 Issue: Volume: Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Noori Maryam¹,Nejadghaderi Seyed Aria²³^ORCID,Arshi Shahnam⁴,Carson‐Chahhoud Kristin⁵⁶,Ansarin Khalil⁷⁸^ORCID,Kolahi Ali‐Asghar⁴^ORCID,Safiri Saeid⁸⁹^ORCID

Affiliation:

1. Student Research Committee School of Medicine Iran University of Medical Sciences Tehran Iran

2. School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

3. Systematic Review and Meta‐analysis Expert Group (SRMEG) Universal Scientific Education and Research Network (USERN) Tehran Iran

4. Social Determinants of Health Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

5. Australian Centre for Precision Health Allied Health and Human Performance University of South Australia South Australia Australia

6. School of Medicine The University of Adelaide Adelaide South Australia Australia

7. Rahat Breath and Sleep Research Center Tabriz University of Medical Sciences Tabriz Iran

8. Tuberculosis and Lung Disease Research Center Tabriz University of Medical Sciences Tabriz Iran

9. Department of Community Medicine Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

Funder

National Institute for Medical Research Development

Tabriz University of Medical Sciences

Shahid Beheshti University of Medical Sciences

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2277

Reference124 articles.

1. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

2. The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses;Journal of Nanobiotechnology;2024-05-31

2. Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19;Biomedicine & Pharmacotherapy;2024-02

3. The influence of Omicron on vaccine efficacy and durability: a neurology perspective;Clinical and Experimental Vaccine Research;2024

4. Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis;Frontiers in Immunology;2023-12-22

5. mRNA Vaccine: an Important Breakthrough in Defeating COVID-19;PROG BIOCHEM BIOPHYS;2023